Demant A/S

Copenhagen Stock Exchange DEMANT.CO

Demant A/S EBITDA for the year ending December 31, 2023: USD 772.37 M

Demant A/S EBITDA is USD 772.37 M for the year ending December 31, 2023, a 28.89% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Demant A/S EBITDA for the year ending December 31, 2022 was USD 599.26 M, a -12.15% change year over year.
Demant A/S EBITDA for the year ending December 31, 2021 was USD 682.12 M, a 73.01% change year over year.
Demant A/S EBITDA for the year ending December 31, 2020 was USD 394.27 M, a -8.55% change year over year.
Demant A/S EBITDA for the year ending December 31, 2019 was USD 431.14 M, a 2.37% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Copenhagen Stock Exchange: DEMANT.CO

Demant A/S

CEO	Mr. Søren Nielsen
IPO Date	May 8, 2000
Location	Denmark
Headquarters	Kongebakken 9
Employees	21,501
Sector	Health Care
Industries Telehealth

Description

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Key trends

Past 5 years